About Transcription elongation factor A protein 3
Transcription elongation factor A protein 3 (TCEA3) is a protein
from Homo sapiens identified by UniProt accession
O75764, 348 residues long.
MolForge cross-references it against 0 known binders and
73 disease associations.
Target properties
| Protein name | Transcription elongation factor A protein 3 |
| UniProt accession | O75764 |
| Gene | TCEA3 |
| Organism | Homo sapiens |
| Length | 348 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (73)
Diseases linked to this target (Open Targets).
- electrocardiography · score 0.37
- calcium measurement · score 0.32
- sex hormone-binding globulin measurement · score 0.32
- apolipoprotein A 1 measurement · score 0.31
- high density lipoprotein cholesterol measurement · score 0.31
- BMI-adjusted waist-hip ratio · score 0.29
- waist-hip ratio · score 0.29
- QT interval · score 0.27
- total blood protein measurement · score 0.23
- low density lipoprotein cholesterol measurement · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75764-F1 | alphafold | PREDICTED | 74.12 | — |
Amino-acid sequence (348 residues)
MGQEEELLRI AKKLEKMVAR KNTEGALDLL KKLHSCQMSI QLLQTTRIGV AVNGVRKHCS DKEVVSLAKV LIKNWKRLLD SPGPPKGEKG EEREKAKKKE KGLECSDWKP EAGLSPPRKK REDPKTRRDS VDSKSSASSS PKRPSVERSN SSKSKAESPK TPSSPLTPTF ASSMCLLAPC YLTGDSVRDK CVEMLSAALK ADDDYKDYGV NCDKMASEIE DHIYQELKST DMKYRNRVRS RISNLKDPRN PGLRRNVLSG AISAGLIAKM TAEEMASDEL RELRNAMTQE AIREHQMAKT GGTTTDLFQC SKCKKKNCTY NQVQTRSADE PMTTFVLCNE CGNRWKFC
Explore Transcription elongation factor A protein 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets